The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Musculoskeletal Disorders Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
The global Musculoskeletal Disorders Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Musculoskeletal Disorders Therapeutics in various end use industries. The expanding demands from the Osteoarthritis, Osteoporosis, Psoriatic Arthritis and Ankylosing Spondylitis, are propelling Musculoskeletal Disorders Therapeutics market. Biologics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Small Molecules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Musculoskeletal Disorders Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Musculoskeletal Disorders Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Musculoskeletal Disorders Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Musculoskeletal Disorders Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Musculoskeletal Disorders Therapeutics covered in this report include AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, Eli Lilly, Merck, Novartis and AstraZeneca, etc.
The global Musculoskeletal Disorders Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Johnson & Johnson
Amgen
Pfizer
F. Hoffmann-La Roche
Eli Lilly
Merck
Novartis
AstraZeneca
Astellas
AB Sciences
3SBio
Samsung Bioepis
Sanofi
Taisho Pharmaceutical
Takeda
Zosano Pharma
LG Life Sciences
Global Musculoskeletal Disorders Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Musculoskeletal Disorders Therapeutics market, Segment by Type:
Biologics
Small Molecules
Global Musculoskeletal Disorders Therapeutics market, by Application
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Musculoskeletal Disorders Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Musculoskeletal Disorders Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Musculoskeletal Disorders Therapeutics in various end use industries. The expanding demands from the Osteoarthritis, Osteoporosis, Psoriatic Arthritis and Ankylosing Spondylitis, are propelling Musculoskeletal Disorders Therapeutics market. Biologics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Small Molecules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Musculoskeletal Disorders Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Musculoskeletal Disorders Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Musculoskeletal Disorders Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Musculoskeletal Disorders Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Musculoskeletal Disorders Therapeutics covered in this report include AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, Eli Lilly, Merck, Novartis and AstraZeneca, etc.
The global Musculoskeletal Disorders Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Johnson & Johnson
Amgen
Pfizer
F. Hoffmann-La Roche
Eli Lilly
Merck
Novartis
AstraZeneca
Astellas
AB Sciences
3SBio
Samsung Bioepis
Sanofi
Taisho Pharmaceutical
Takeda
Zosano Pharma
LG Life Sciences
Global Musculoskeletal Disorders Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Musculoskeletal Disorders Therapeutics market, Segment by Type:
Biologics
Small Molecules
Global Musculoskeletal Disorders Therapeutics market, by Application
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Musculoskeletal Disorders Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Musculoskeletal Disorders Therapeutics
1.1 Musculoskeletal Disorders Therapeutics Market Overview
1.1.1 Musculoskeletal Disorders Therapeutics Product Scope
1.1.2 Musculoskeletal Disorders Therapeutics Market Status and Outlook
1.2 Global Musculoskeletal Disorders Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Musculoskeletal Disorders Therapeutics Market Size by Region (2018-2029)
1.4 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Musculoskeletal Disorders Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Musculoskeletal Disorders Therapeutics Market Size (2018-2029)
1.6.1 North America Musculoskeletal Disorders Therapeutics Market Size (2018-2029)
1.6.2 Europe Musculoskeletal Disorders Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size (2018-2029)
1.6.4 Latin America Musculoskeletal Disorders Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size (2018-2029)
2 Musculoskeletal Disorders Therapeutics Market by Type
2.1 Introduction
2.1.1 Biologics
2.1.2 Small Molecules
2.2 Global Musculoskeletal Disorders Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Musculoskeletal Disorders Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Musculoskeletal Disorders Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Musculoskeletal Disorders Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue Breakdown by Type (2018-2029)
3 Musculoskeletal Disorders Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Osteoarthritis
3.1.2 Osteoporosis
3.1.3 Psoriatic Arthritis
3.1.4 Ankylosing Spondylitis
3.1.5 Fibromyalgia
3.2 Global Musculoskeletal Disorders Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Musculoskeletal Disorders Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Musculoskeletal Disorders Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Musculoskeletal Disorders Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Musculoskeletal Disorders Therapeutics Revenue Breakdown by Application (2018-2029)
4 Musculoskeletal Disorders Therapeutics Competition Analysis by Players
4.1 Global Musculoskeletal Disorders Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2022)
4.3 Date of Key Players Enter into Musculoskeletal Disorders Therapeutics Market
4.4 Global Top Players Musculoskeletal Disorders Therapeutics Headquarters and Area Served
4.5 Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Musculoskeletal Disorders Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.1.4 AbbVie Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.2.4 Johnson & Johnson Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Amgen
5.3.1 Amgen Profile
5.3.2 Amgen Main Business
5.3.3 Amgen Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.3.4 Amgen Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.4.4 Pfizer Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.6.4 Eli Lilly Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.7.4 Merck Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.8.4 Novartis Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 AstraZeneca
5.9.1 AstraZeneca Profile
5.9.2 AstraZeneca Main Business
5.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.9.4 AstraZeneca Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 AstraZeneca Recent Developments
5.10 Astellas
5.10.1 Astellas Profile
5.10.2 Astellas Main Business
5.10.3 Astellas Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.10.4 Astellas Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Astellas Recent Developments
5.11 AB Sciences
5.11.1 AB Sciences Profile
5.11.2 AB Sciences Main Business
5.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.11.4 AB Sciences Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 AB Sciences Recent Developments
5.12 3SBio
5.12.1 3SBio Profile
5.12.2 3SBio Main Business
5.12.3 3SBio Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.12.4 3SBio Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 3SBio Recent Developments
5.13 Samsung Bioepis
5.13.1 Samsung Bioepis Profile
5.13.2 Samsung Bioepis Main Business
5.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.13.4 Samsung Bioepis Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Samsung Bioepis Recent Developments
5.14 Sanofi
5.14.1 Sanofi Profile
5.14.2 Sanofi Main Business
5.14.3 Sanofi Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.14.4 Sanofi Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 Sanofi Recent Developments
5.15 Taisho Pharmaceutical
5.15.1 Taisho Pharmaceutical Profile
5.15.2 Taisho Pharmaceutical Main Business
5.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.15.4 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Taisho Pharmaceutical Recent Developments
5.16 Takeda
5.16.1 Takeda Profile
5.16.2 Takeda Main Business
5.16.3 Takeda Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.16.4 Takeda Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.16.5 Takeda Recent Developments
5.17 Zosano Pharma
5.17.1 Zosano Pharma Profile
5.17.2 Zosano Pharma Main Business
5.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.17.4 Zosano Pharma Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.17.5 Zosano Pharma Recent Developments
5.18 LG Life Sciences
5.18.1 LG Life Sciences Profile
5.18.2 LG Life Sciences Main Business
5.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Products, Services and Solutions
5.18.4 LG Life Sciences Musculoskeletal Disorders Therapeutics Revenue (US$ Million) & (2018-2023)
5.18.5 LG Life Sciences Recent Developments
6 North America
6.1 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Musculoskeletal Disorders Therapeutics Market Dynamics
11.1 Musculoskeletal Disorders Therapeutics Industry Trends
11.2 Musculoskeletal Disorders Therapeutics Market Drivers
11.3 Musculoskeletal Disorders Therapeutics Market Challenges
11.4 Musculoskeletal Disorders Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
